Business Insights, Sep 2009, Pages: 183
counter measures.
Use this report to:
- What are the major trends driving the biodefense market?
- What is the current state of R&D in the biodefense market?
- How has the regulatory pathway changed
Bizacumen Inc., Nov 2009, Pages: 125
the opportunity to avail flexibility, quicker time to market, and lower scale-up costs. Thus, companies will be able to meet growing demand for new drugs and focus on their core competencies. Secondly, outsourcing
GlobalData, Aug 2011, Pages: 46
on the platform technologies include spi-VEC, MVAtor, SMIP therapeutics, SCORPION therapeutics and TRU-ADhanCe technology. It primarily operates in two repotable segments: biodefense and biosciences. Emergent
Markets and Markets, May 2011, Pages: 331
DNA) and Complementary DNA Microarrays (cDNA)
On the basis of geography:
- North America,
- Europe,
- Asia,
- Rest of the World.
Each section will provide market data, market drivers, trends and opportunities, top
PharmaVision, Nov 2007, Pages: 78
the market is evolving & the influence that delivery may have on the development of prophylactic vaccines for complex and emerging infectious diseases, biodefense vaccines and therapeutic vaccines
-identify key pharma
GlobalData, Sep 2011, Pages: 40
Of $407.7m For Q2 2011
Jun 27, 2011: PPD Appoints Edward Ian As Vice President Of Clinical Development For Asia Pacific
May 31, 2011: PPD Receives US Army Contract To Support Biodefense And Vaccine
CurrentPartnering, Jan 2012, Pages +: 4000
announced worldwide.
Chapter 1 provides an introduction to the report, whilst chapter 2 provides an overview of partnering trends, respectively, in 2011. The key partnering deals of 2011 are reviewed
CurrentPartnering, Jan 2012, Pages +: 5000
and M&A deals announced worldwide.
Chapter 1 provides an introduction to the report, whilst chapters 2 and 3 provide an overview of partnering and M&A trends, respectively, in 2011. The key partnering
Dedalus Consulting Inc., May 2006, Pages: 55
A detailed report analyzing current trends in the dynamic and growing market for BioChips and BioMEMS including DNA chips, lab-on-a-chip, biosensors, drug delivery systems, microfluidic devices
Dedalus Consulting Inc., April 2006, Pages: 150
A detailed report analyzing current trends in the dynamic and growing market for BioChips and BioMEMS including DNA chips, lab-on-a-chip, biosensors, drug delivery systems, and biomems implants
GlobalData, Oct 2011, Pages: 18
the trends and developments driving the medical devices pipeline and technology landscape globally.
- Design and develop your product development, marketing and sales strategies.
- Exploit M&A opportunities
GlobalData, Sep 2011, Pages: 42
and Biodefense. The products under BioTherapeutics segment include, orBec, SGX201, SGX203 and LPM Leuprolide and in Biodefence segment , the company has RiVax is a lead product, a proprietary vaccine developed
Global Industry Analysts, Inc., Jan 2011, Pages: 804
: Opportunities
SARS - A Review
Vaccinations Recommended for Travel to High-Risk Areas
Mechanisms for Vaccine Delivery
Edible Vaccines
Oral Vaccines
Tablet Based Vaccines
Mucosal Delivery
Transdermal
Frost & Sullivan, July 2004
-An Overview
Scope and Methodology
Scope and Segmentation of the Research Service
Methodology
2 NANOMEDICINE: GROWTH OPPORTUNITY ANALYSIS
Nanomedicine: Research Trends and Challenges
Research Trends
RNCOS E-Services Private Limited, Nov 2007, Pages: 135
, current and future market trends.
- Discussion on major vaccines and their markets.
- Future forecast of major vaccines.
- Analysis of various challenges and opportunities for the industry.
- Categories
Jain PharmaBiotech, Feb 2012, Pages: 1029
Bead ARray Counter
ProteinChip-based detection of bioterroism agents
TIGER biosensor
The PathAlert? Detection System
VereThreat™
Concluding remarks about biodefense applications of diagnostics
11
Datamonitor, Dec 2008, Pages: 267
as key opportunity 33
CSL: controlling the Australian vaccines market 34
Crucell: attractive dual business model 35
Emergent BioSolutions: focusing on biodefense 35
Intercell: the multi-partner company 36
Frost & Sullivan, March 2004
AND THEIR APPLICATIONS
Introduction
Introduction
Key Developments
Research Trends - Companies
Diversa Picks Best of Extremophiles
Biodefense and Industrial Projects
Research Trends - Universities
Applied
